FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

402711000001105: Farlutal 500 tablets (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17223901000001112 Farlutal 500 tablets (Pfizer Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17224001000001110 Farlutal 500 tablets (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Farlutal 500 tablets (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Farlutal 500 tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Farlutal 500 tablets (Pfizer Ltd) Is a Product containing precisely medroxyprogesterone acetate 500 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Farlutal 500 tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Farlutal 500 tablets (Pfizer Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Farlutal 500 tablets (Pfizer Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Farlutal 500 tablets (Pfizer Ltd) Has active ingredient Progesterone false Inferred relationship Existential restriction modifier
Farlutal 500 tablets (Pfizer Ltd) Has active ingredient Medroxyprogesterone acetate false Inferred relationship Existential restriction modifier
Farlutal 500 tablets (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Farlutal 500 tablets (Pfizer Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Farlutal 500 tablets (Pfizer Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Farlutal 500 tablets (Pfizer Ltd) Is a Farlutal true Inferred relationship Existential restriction modifier
Farlutal 500 tablets (Pfizer Ltd) Has specific active ingredient Medroxyprogesterone acetate true Inferred relationship Existential restriction modifier
Farlutal 500 tablets (Pfizer Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Farlutal 500 tablets (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Farlutal 500 tablets (Pfizer Ltd) 56 tablet 4 x 14 tablets Is pack of False Farlutal 500 tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier
Farlutal 500 tablets (Pfizer Ltd) 56 tablet 4 x 14 tablets Has AMP True Farlutal 500 tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start